Last reviewed · How we verify
E. Coli Cervicitis
Approved treatments
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Ceftazidim · Tel-Aviv Sourasky Medical Center
Clinical guidelines
- FDA label — 1L
Ceftazidime is indicated for the treatment of gynecologic infections, including endometritis and cervicitis, caused by Escherichia coli. - FDA label — 1L
Ceftazidime is indicated for the treatment of gynecologic infections, including endometritis, caused by Escherichia coli.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Cervicitis patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Cervicitis treatment landscape brief
- E. Coli Cervicitis treatment updates RSS
Frequently asked questions about E. Coli Cervicitis
What drugs treat E. Coli Cervicitis?
Tracked treatments include Fortaz, Ceftazidim.
What is the treatment for E. Coli Cervicitis?
Standard treatment for E. Coli Cervicitis includes Fortaz, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for E. Coli Cervicitis?
FDA label publishes guidelines for E. Coli Cervicitis. 2 guideline references tracked.
Related
- Treatment landscape: E. Coli Cervicitis patent cliff · E. Coli Cervicitis CI report
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Ceftazidim · Tel-Aviv Sourasky Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing